Bicara Therapeutics Inc. (BCAX) Earnings
|
Expand Research on BCAX
| Next EPS Date | 11/17/26 | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | N/A | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | N/A | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/26  |
Q326 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.82 | N/A | N/A | N/A | N/A | N/A |  | | Details | |
| 5/11/26 | Q126 | -$0.93 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 3/30/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | -$0.67 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 9/3/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | -$0.68 | N/A | N/A | N/A | N/A | N/A | | | Details |
